Early Events in Peripheral Regulatory T Cell Induction via the Nasal Mucosa
Open Access
- 1 November 2003
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 171 (9) , 4592-4603
- https://doi.org/10.4049/jimmunol.171.9.4592
Abstract
Nasal application of soluble Ags leads to Ag-specific suppression of systemic immune responses. This tolerance can be transferred to naive mice by CD4+ regulatory T cells (TR cells) from the spleen, but little is known about the induction of mucosal TR cells in vivo. To investigate the induction of TR cells in the nose-draining cervical lymph node (CLN), CD4+ T cells from DO11.10 OVA TCR transgenic mice were transferred to BALB/c recipients. Within 48 h after nasal OVA application, CD4+ DO11.10 T cells in CLN, but not in the peripheral lymph node, had divided. Similarly, nonmucosal (i.m.) OVA application also induced CD4+ DO11.10 T cells to proliferate in the draining inguinal lymph node (ILN), yet more vigorously and with different kinetics than the CD4+ DO11.10 T cells in CLN. Functional analysis revealed that only proliferating CD4+ DO11.10 T cells from CLN, and not ILN, could transfer tolerance to naive recipients. CD4+ DO11.10 T cells from CLN were phenotypically similar to CD4+ DO11.10 T cells from ILN, however, in CLN a higher percentage of CD25+ proliferating CD4+ DO11.10 T cells were detected compared with ILN. CD25 is not a discriminative marker for mucosal TR cells because both CD25+ and CD25− CD4+ DO11.10 T cells from the CLN could suppress delayed type hypersensitivity responses in adoptive transfer. These findings demonstrate that although striking similarities exist between the differentiation of TR and effector T cells, this does not include their function. We are the first to demonstrate that functional TR cells, which reside within both CD25+ and CD25− subsets, can be isolated from CLN as early as 3 days after nasal OVA application.Keywords
This publication has 48 references indexed in Scilit:
- Infectious ToleranceThe Journal of Experimental Medicine, 2002
- In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing CytokinesThe Journal of Experimental Medicine, 2002
- CD38+ CD45RBlow CD4+ T cells: a population of T cells with immune regulatory activitiesin vitroEuropean Journal of Immunology, 1998
- T CELL MEMORYAnnual Review of Immunology, 1998
- CD4+ T-cell memory, CD45R subsets and the persistence of antigen—a unifying conceptImmunology Today, 1998
- A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells.The Journal of Experimental Medicine, 1996
- Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivoInternational Immunology, 1996
- Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivoImmunity, 1994
- Turnover of naive- and memory-phenotype T cells.The Journal of Experimental Medicine, 1994
- Characterization of antigen-specific CD4+ effector T cells in vivo: immunization results in a transient population of MEL-14-, CD45RB- helper cells that secretes interleukin 2 (IL-2), IL-3, IL-4, and interferon gamma.The Journal of Experimental Medicine, 1991